[go: up one dir, main page]

FI962869L - Ihon läpi absorboituvissa oleva preparaatti - Google Patents

Ihon läpi absorboituvissa oleva preparaatti Download PDF

Info

Publication number
FI962869L
FI962869L FI962869A FI962869A FI962869L FI 962869 L FI962869 L FI 962869L FI 962869 A FI962869 A FI 962869A FI 962869 A FI962869 A FI 962869A FI 962869 L FI962869 L FI 962869L
Authority
FI
Finland
Prior art keywords
absorbed
skin
preparation
Prior art date
Application number
FI962869A
Other languages
English (en)
Swedish (sv)
Other versions
FI962869A7 (fi
FI962869A0 (fi
Inventor
Kaneto Uekama
Tetsumi Irie
Michio Hara
Yasuhide Horiuchi
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of FI962869A0 publication Critical patent/FI962869A0/fi
Publication of FI962869A7 publication Critical patent/FI962869A7/fi
Publication of FI962869L publication Critical patent/FI962869L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI962869A 1994-11-17 1995-11-16 Ihon läpi absorboituvissa oleva preparaatti FI962869L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28379394 1994-11-17
PCT/JP1995/002350 WO1996015793A1 (en) 1994-11-17 1995-11-16 Percutaneously absorbable preparation

Publications (3)

Publication Number Publication Date
FI962869A0 FI962869A0 (fi) 1996-07-16
FI962869A7 FI962869A7 (fi) 1996-09-16
FI962869L true FI962869L (fi) 1996-09-16

Family

ID=17670220

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962869A FI962869L (fi) 1994-11-17 1995-11-16 Ihon läpi absorboituvissa oleva preparaatti

Country Status (15)

Country Link
US (1) US5854281A (fi)
EP (1) EP0742011B1 (fi)
JP (1) JP4024852B2 (fi)
KR (1) KR100413202B1 (fi)
CN (1) CN1102850C (fi)
AT (1) ATE220911T1 (fi)
AU (1) AU713461B2 (fi)
CA (1) CA2181364A1 (fi)
DE (1) DE69527507T2 (fi)
ES (1) ES2180658T3 (fi)
FI (1) FI962869L (fi)
NO (1) NO962972L (fi)
PT (1) PT742011E (fi)
TW (1) TW413637B (fi)
WO (1) WO1996015793A1 (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2254925A1 (en) * 1997-03-13 1998-09-17 Shigeyasu Annoh Drugs for relieving diabetic vascular lesion
US6114337A (en) * 1998-11-27 2000-09-05 Pugliese; Peter T. Zwitteronic-fatty acid compounds having anti-inflammatory properties
US6448251B1 (en) * 1997-11-28 2002-09-10 Peter T. Pugliese Zwitterionic-fatty acid compounds having anti-inflammatory properties
CA2335736A1 (en) * 1998-06-25 1999-12-29 Lavipharm Laboratories, Inc. A device and method for the treatment of erectile dysfunction
US8119159B2 (en) * 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US20070148228A1 (en) * 1999-02-22 2007-06-28 Merrion Research I Limited Solid oral dosage form containing an enhancer
US7658938B2 (en) * 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
PT1242012E (pt) * 1999-11-24 2010-03-31 Agile Therapeutics Inc Sistema e processo melhorado de libertação transdérmica de contraceptivo
AU2002256471B2 (en) * 2001-05-03 2007-05-24 Allergan, Inc. Compositions having enhanced pharmacokinetic characteristics
EP1390383B1 (en) * 2001-05-11 2012-02-29 Isis Pharmaceuticals, Inc. Antisense permeation enhancers
CA2529351C (en) 2003-05-09 2012-04-17 Toray Industries, Inc. Use of prostaglandin i for enhancing the effect of a renin-angiotensin system inhibitor on a renal disease
BRPI0506851A (pt) * 2004-01-14 2007-06-12 Lavipharm Lab Inc dispositivo de distribuição transdérmica para distribuir antagonistas de cálcio do tipo diidropiridina contendo pelo menos um ácido graxo
US20090074844A1 (en) * 2005-04-28 2009-03-19 Ono Pharmaceutical Co., Ltd. Trenadermal absorption preparation
BRPI0710503A2 (pt) * 2006-04-07 2011-08-16 Merrion Res Iii Ltd uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
EP2040731A4 (en) * 2006-06-09 2010-05-19 Merrion Res Iii Ltd SOLID DOSAGE FORM FOR ORAL ADMINISTRATION CONTAINING AN ACTIVATOR
JP5671451B2 (ja) 2008-05-07 2015-02-18 メリオン・リサーチ・Ｉｉｉ・リミテッド ＧｎＲＨ関連化合物の組成物および調製プロセス
US20130274352A1 (en) * 2009-04-14 2013-10-17 The Regents Of The University Of California Oral Drug Devices and Drug Formulations
JP2013514976A (ja) 2009-12-16 2013-05-02 ノッド ファーマシューティカルズ， インコーポレイテッド 経口薬物送達のための組成物および方法
US20110142889A1 (en) * 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
WO2011120033A1 (en) 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
JP2014501784A (ja) 2011-01-07 2014-01-23 メリオン・リサーチ・Ｉｉｉ・リミテッド 経口投与用の鉄の医薬組成物
JP5878715B2 (ja) * 2011-09-22 2016-03-08 久光製薬株式会社 貼付剤
JP6104230B2 (ja) * 2012-03-22 2017-03-29 帝國製薬株式会社 経皮吸収型製剤
TWI643638B (zh) * 2013-08-09 2018-12-11 帝國製藥股份有限公司 含有貝前列素（Ｂｅｒａｐｒｏｓｔ）之貼附劑
US10265384B2 (en) 2015-01-29 2019-04-23 Novo Nordisk A/S Tablets comprising GLP-1 agonist and enteric coating
EP3563843A4 (en) * 2016-12-28 2019-12-11 FUJIFILM Toyama Chemical Co., Ltd. TOPICAL COMPOSITION
US20230391809A1 (en) * 2022-06-07 2023-12-07 Biomimetix Jv, Llc Hydrophobic compositions including a hydrophilic active ingredient and methods relating thereto

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58124778A (ja) * 1982-01-20 1983-07-25 Toray Ind Inc ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
ZA875317B (en) * 1986-08-01 1988-01-25 Warner-Lambert Company Transdermal compositions
DE3779999T2 (de) * 1986-11-14 1992-12-10 Theratech Inc Erhoehung des penetrationsvermoegens mittels eines aus die zellhuelle veraendernden substanzen und kurzkettigen alkoholen bestehenden binaeren systems.
WO1988009676A1 (en) * 1987-06-01 1988-12-15 Warner-Lambert Company Fatty acids and their small chain esters as penetration enhancers in aqueous systems
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
JP2503672B2 (ja) 1989-07-28 1996-06-05 井関農機株式会社 草刈機の刈草収容装置
JPH0737389B2 (ja) * 1989-08-29 1995-04-26 久光製薬株式会社 プロスタグランジンｅ１含有の軟膏剤
JP2838297B2 (ja) * 1989-11-02 1998-12-16 日産化学工業株式会社 コルヒチン含有外用剤
JPH082801B2 (ja) * 1989-11-09 1996-01-17 株式会社資生堂 経皮吸収促進剤及び皮膚外用剤
JP3243564B2 (ja) * 1990-08-20 2002-01-07 リードケミカル株式会社 外用貼付剤
JP3059204B2 (ja) * 1990-10-25 2000-07-04 帝國製薬株式会社 安定なプロスタグランジンｉ▲下１▼類含有皮膚適用組成物
JPH04243827A (ja) * 1991-01-25 1992-08-31 Sumitomo Pharmaceut Co Ltd プロスタグランジン誘導体含有溶解型軟膏剤
DE4124693A1 (de) * 1991-07-22 1993-01-28 Schering Ag Carbacyclinderivate als mittel zur behandlung von vitiligo
DE4124695C2 (de) * 1991-07-22 1994-12-22 Blitstein Willinger Eveline Dr Verwendung von Carbacyclinderivaten zur Behandlung von Psoriasis vulgaris
DE4210165A1 (de) * 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
ATE188119T1 (de) * 1992-02-07 2000-01-15 Kaken Pharma Co Ltd Heilmittel für wunden und hämorrhoiden
JP3102141B2 (ja) * 1992-05-29 2000-10-23 東レ株式会社 養毛育毛剤
JP3115482B2 (ja) * 1994-01-28 2000-12-04 帝人株式会社 プロスタサイクリン類含有皮膚適用組成物

Also Published As

Publication number Publication date
AU713461B2 (en) 1999-12-02
ES2180658T3 (es) 2003-02-16
FI962869A7 (fi) 1996-09-16
TW413637B (en) 2000-12-01
KR100413202B1 (ko) 2004-04-13
DE69527507T2 (de) 2002-11-07
EP0742011A4 (en) 1997-08-20
PT742011E (pt) 2002-10-31
US5854281A (en) 1998-12-29
NO962972D0 (no) 1996-07-16
NO962972L (no) 1996-09-16
AU3881195A (en) 1996-06-17
DE69527507D1 (de) 2002-08-29
WO1996015793A1 (en) 1996-05-30
CN1140412A (zh) 1997-01-15
EP0742011A1 (en) 1996-11-13
CN1102850C (zh) 2003-03-12
EP0742011B1 (en) 2002-07-24
JP4024852B2 (ja) 2007-12-19
CA2181364A1 (en) 1996-05-30
FI962869A0 (fi) 1996-07-16
ATE220911T1 (de) 2002-08-15

Similar Documents

Publication Publication Date Title
FI962869L (fi) Ihon läpi absorboituvissa oleva preparaatti
FI951963A0 (fi) Turvalaite
DE69524185D1 (de) Zwei-walzen-giessverfahren
DK0739275T3 (da) Fastgørelsesorgan
FI971228A7 (fi) Säilöntäaineita
FI955503A0 (fi) Liitoslaite
NO971996L (no) Tre-kompositt
DE19580647D2 (de) Rastvorrichtung
FI952629L (fi) Kefiksiimivalmiste
KR960008368A (ko) 투영장치 및 투영장치의 핀트조정방법
DE69503368D1 (de) Dermatologisches präparat
KR960000131U (ko) 착즙기
DE69503568D1 (de) Sperrvorrichtung
DE59502822D1 (de) Thermokanne
KR960000124U (ko) 착즙기
KR960003669U (ko) 착즙기
KR960006801U (ko) 녹즙기
KR960016067U (ko) 착즙기
KR960000129U (ko) 착즙기
KR960009699U (ko) 착즙기
KR950022603U (ko) 운동구겸용 침대
SE9403012D0 (sv) Preparation
SE9400792D0 (sv) The Hoock
ITRE940066U1 (it) Cassaforte perfezionata
SE9402066D0 (sv) Underlägget